BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naranbhai V, Carrington M. Host genetic variation and HIV disease: from mapping to mechanism. Immunogenetics 2017;69:489-98. [PMID: 28695282 DOI: 10.1007/s00251-017-1000-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Mehlotra RK. Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots. Curr HIV/AIDS Rep 2018;15:431-40. [PMID: 30218255 DOI: 10.1007/s11904-018-0417-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Casanova JL, Abel L. Human genetics of infectious diseases: Unique insights into immunological redundancy. Semin Immunol 2018;36:1-12. [PMID: 29254755 DOI: 10.1016/j.smim.2017.12.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 10.4] [Reference Citation Analysis]
3 Boswell MT, Rowland-Jones SL. Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid. Clin Exp Immunol 2019;196:305-17. [PMID: 30773620 DOI: 10.1111/cei.13280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Dijkstra M, Prins H, Prins JM, Reiss P, Boucher C, Verbon A, Rokx C, de Bree G. Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment. BMJ Open 2021;11:e048582. [PMID: 34845066 DOI: 10.1136/bmjopen-2020-048582] [Reference Citation Analysis]
5 Adewoye AB, Shrine N, Odenthal-Hesse L, Welsh S, Malarstig A, Jelinsky S, Kilty I, Tobin MD, Hollox EJ, Wain LV. Human CCL3L1 copy number variation, gene expression, and the role of the CCL3L1-CCR5 axis in lung function. Wellcome Open Res 2018;3:13. [PMID: 29682616 DOI: 10.12688/wellcomeopenres.13902.2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Shieh M, Chitnis N, Monos D. Human Leukocyte Antigen and Disease Associations. Clinics in Laboratory Medicine 2018;38:679-93. [DOI: 10.1016/j.cll.2018.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Ni J, Wang D, Wang S. The CCR5-Delta32 Genetic Polymorphism and HIV-1 Infection Susceptibility: a Meta-analysis. Open Med (Wars) 2018;13:467-74. [PMID: 30426084 DOI: 10.1515/med-2018-0062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bashirova AA, Viard M, Naranbhai V, Grifoni A, Garcia-Beltran W, Akdag M, Yuki Y, Gao X, O'hUigin C, Raghavan M, Wolinsky S, Bream JH, Duggal P, Martinson J, Michael NL, Kirk GD, Buchbinder SP, Haas D, Goedert JJ, Deeks SG, Fellay J, Walker B, Goulder P, Cresswell P, Elliott T, Sette A, Carlson J, Carrington M. HLA tapasin independence: broader peptide repertoire and HIV control. Proc Natl Acad Sci U S A 2020;117:28232-8. [PMID: 33097667 DOI: 10.1073/pnas.2013554117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
9 Bontrop RE. Foreword: Immunogenetics special issue 2017. Immunogenetics 2017;69:479-80. [PMID: 28695281 DOI: 10.1007/s00251-017-1012-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Boswell MT, Yindom LM, Hameiri-Bowen D, McHugh G, Dauya E, Bandason T, Mujuru H, Esbjörnsson J, Ferrand RA, Rowland-Jones S. TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection. AIDS 2021;35:2445-50. [PMID: 34870928 DOI: 10.1097/QAD.0000000000003053] [Reference Citation Analysis]
11 Olvera A, Cedeño S, Llano A, Mothe B, Sanchez J, Arsequell G, Brander C. Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity? Front Immunol 2020;11:573928. [PMID: 33552045 DOI: 10.3389/fimmu.2020.573928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mehlotra RK. New Knowledge About CCR5, HIV Infection, and Disease Progression: Is "Old" Still Valuable? AIDS Res Hum Retroviruses 2020;36:795-9. [PMID: 32615790 DOI: 10.1089/AID.2020.0060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kulkarni S, Lied A, Kulkarni V, Rucevic M, Martin MP, Walker-Sperling V, Anderson SK, Ewy R, Singh S, Nguyen H, McLaren PJ, Viard M, Naranbhai V, Zou C, Lin Z, Gatanaga H, Oka S, Takiguchi M, Thio CL, Margolick J, Kirk GD, Goedert JJ, Hoots WK, Deeks SG, Haas DW, Michael N, Walker B, Le Gall S, Chowdhury FZ, Yu XG, Carrington M. CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome. Nat Immunol 2019;20:824-34. [PMID: 31209403 DOI: 10.1038/s41590-019-0406-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
14 Pérez-yanes S, Pernas M, Marfil S, Cabrera-rodríguez R, Ortiz R, Urrea V, Rovirosa C, Estévez-herrera J, Olivares I, Casado C, Lopez-galindez C, Blanco J, Valenzuela-fernández A. The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis. Front Microbiol 2022;13:763039. [DOI: 10.3389/fmicb.2022.763039] [Reference Citation Analysis]
15 Gabrielaite M, Bennedbæk M, Zucco AG, Ekenberg C, Murray DD, Kan VL, Touloumi G, Vandekerckhove L, Turner D, Neaton J, Lane HC, Safo S, Arenas-Pinto A, Polizzotto MN, Günthard HF, Lundgren JD, Marvig RL; INSIGHT START trial group. Human immunotypes impose selection on viral genotypes through viral epitope specificity. J Infect Dis 2021:jiab253. [PMID: 33974707 DOI: 10.1093/infdis/jiab253] [Reference Citation Analysis]
16 Maibach V, Langergraber K, Leendertz FH, Wittig RM, Vigilant L. Differences in MHC-B diversity and KIR epitopes in two populations of wild chimpanzees. Immunogenetics 2019;71:617-33. [PMID: 31797008 DOI: 10.1007/s00251-019-01148-3] [Reference Citation Analysis]
17 Olson E, Geng J, Raghavan M. Polymorphisms of HLA-B: influences on assembly and immunity. Curr Opin Immunol 2020;64:137-45. [PMID: 32619904 DOI: 10.1016/j.coi.2020.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Smatti MK, Alkhatib HA, Al Thani AA, Yassine HM. Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents. Front Med 2022;9:802312. [DOI: 10.3389/fmed.2022.802312] [Reference Citation Analysis]
19 Zaidane I, Ouladlahsen A, Bensghir R, Chihab H, Jadid FZ, Fɩhry RE, Baba H, Filali KME, Oudghiri M, Wakrim L, Benjelloun S, Ezzikouri S. An assessment of toll-like receptor 7 and 8 gene polymorphisms with susceptibility to HIV-1 infection, AIDS development and response to antiretroviral therapy. Immunol Lett 2020;227:88-95. [PMID: 32888973 DOI: 10.1016/j.imlet.2020.08.008] [Reference Citation Analysis]
20 Turk G, Ghiglione Y, Hormanstorfer M, Laufer N, Coloccini R, Salido J, Trifone C, Ruiz MJ, Falivene J, Holgado MP, Caruso MP, Figueroa MI, Salomón H, Giavedoni LD, Pando MLÁ, Gherardi MM, Rabinovich RD, Pury PA, Sued O. Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count? Viruses 2018;10:E34. [PMID: 29342870 DOI: 10.3390/v10010034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sanchez-Mazas A, Černý V, Di D, Buhler S, Podgorná E, Chevallier E, Brunet L, Weber S, Kervaire B, Testi M, Andreani M, Tiercy JM, Villard J, Nunes JM. The HLA-B landscape of Africa: Signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protection. Mol Ecol 2017;26:6238-52. [PMID: 28950417 DOI: 10.1111/mec.14366] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
22 Khanaliha K, Bokharaei-salim F, Donyavi T, Nahand JS, Marjani A, Jamshidi S, Khatami A, Moghaddas M, Esghaei M, Fakhim A. Evaluation of CCR5-Δ32 mutation and HIV-1 surveillance drug-resistance mutations in peripheral blood mononuclear cells of long-term non progressors of HIV-1-infected individuals. Future Virology. [DOI: 10.2217/fvl-2021-0028] [Reference Citation Analysis]
23 Olivier IS, Cacabelos R, Naidoo V. Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics. Int J Mol Sci 2018;19:E3594. [PMID: 30441796 DOI: 10.3390/ijms19113594] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
24 Ekenberg C, Tang MH, Zucco AG, Murray DD, MacPherson CR, Hu X, Sherman BT, Losso MH, Wood R, Paredes R, Molina JM, Helleberg M, Jina N, Kityo CM, Florence E, Polizzotto MN, Neaton JD, Lane HC, Lundgren JD. Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. J Infect Dis 2019;220:1325-34. [PMID: 31219150 DOI: 10.1093/infdis/jiz294] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
25 Hersberger M, Schlaepfer E, Buehler M, Bochud PY, Vernazza P, Marti-Jaun J, Nemeth J, Zwahlen M, Schmidlin K, Speck RF; Swiss HIV Cohort Study. Polymorphisms of SOCS-1 Are Associated With a Rapid HIV Progression Rate. J Acquir Immune Defic Syndr 2020;84:189-95. [PMID: 32097250 DOI: 10.1097/QAI.0000000000002319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fantuzzi L, Tagliamonte M, Gauzzi MC, Lopalco L. Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders. Cell Mol Life Sci 2019;76:4869-86. [PMID: 31377844 DOI: 10.1007/s00018-019-03255-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
27 Wei X, Wang S, Li Z, Li Z, Qu Z, Wang S, Zou B, Liang R, Xia C, Zhang N. Peptidomes and Structures Illustrate Two Distinguishing Mechanisms of Alternating the Peptide Plasticity Caused by Swine MHC Class I Micropolymorphism. Front Immunol 2021;12:592447. [PMID: 33717070 DOI: 10.3389/fimmu.2021.592447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lee GQ, Reddy K, Einkauf KB, Gounder K, Chevalier JM, Dong KL, Walker BD, Yu XG, Ndung'u T, Lichterfeld M. HIV-1 DNA sequence diversity and evolution during acute subtype C infection. Nat Commun 2019;10:2737. [PMID: 31227699 DOI: 10.1038/s41467-019-10659-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
29 Mehlotra RK. Chemokine receptor gene polymorphisms and COVID-19: Could knowledge gained from HIV/AIDS be important? Infect Genet Evol 2020;85:104512. [PMID: 32858232 DOI: 10.1016/j.meegid.2020.104512] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Lunardi LW, Bragatte MAS, Vieira GF. The influence of HLA/HIV genetics on the occurrence of elite controllers and a need for therapeutics geotargeting view. Braz J Infect Dis 2021;25:101619. [PMID: 34562387 DOI: 10.1016/j.bjid.2021.101619] [Reference Citation Analysis]
31 McLaren PJ, Fellay J. HIV-1 and human genetic variation. Nat Rev Genet 2021. [PMID: 34168330 DOI: 10.1038/s41576-021-00378-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Aflalo A, Boyle LH. Polymorphisms in MHC class I molecules influence their interactions with components of the antigen processing and presentation pathway. Int J Immunogenet 2021;48:317-25. [PMID: 34176210 DOI: 10.1111/iji.12546] [Reference Citation Analysis]
33 Jaumdally SZ, Liebenberg LJP, Gumbi PP, Little F, Jaspan HB, Gamieldien H, Tiemessen CT, Coetzee D, Martin DP, Williamson C, Williamson AL, Passmore JS. Partner HIV Serostatus Impacts Viral Load, Genital HIV Shedding, and Immune Activation in HIV-Infected Individuals. J Acquir Immune Defic Syndr 2019;82:51-60. [PMID: 31169767 DOI: 10.1097/QAI.0000000000002089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]